Goldman Sachs
USNA icon

Goldman Sachs’s Usana Health Sciences USNA Stock Holding History

Goldman Sachs’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.59M Sell
91,149
-1,134
-1% -$22.5K ﹤0.01% 4733
2025
Q4 		$1.81M Sell
92,283
-62,255
-40% -$1.29M ﹤0.01% 4682
2025
Q3 		$4.26M Sell
154,538
-12,326
-7% -$379K ﹤0.01% 3792
2025
Q2 		$5.09M Buy
166,864
+90,307
+118% +$2.56M ﹤0.01% 3391
2025
Q1 		$2.06M Sell
76,557
-23,948
-24% -$758K ﹤0.01% 4134
2024
Q4 		$3.61M Buy
100,505
+42,884
+74% +$1.6M ﹤0.01% 3780
2024
Q3 		$2.18M Buy
57,621
+108
+0.2% +$4.44K ﹤0.01% 4088
2024
Q2 		$2.6M Buy
57,513
+18,712
+48% +$861K ﹤0.01% 3731
2024
Q1 		$1.88M Buy
38,801
+19,169
+98% +$939K ﹤0.01% 3914
2023
Q4 		$1.05M Sell
19,632
-46,751
-70% -$2.36M ﹤0.01% 4356
2023
Q3 		$3.89M Buy
66,383
+7,658
+13% +$479K ﹤0.01% 3211
2023
Q2 		$3.7M Sell
58,725
-41,726
-42% -$2.66M ﹤0.01% 3378
2023
Q1 		$6.32M Buy
100,451
+55,360
+123% +$3.3M ﹤0.01% 2830
2022
Q4 		$2.4M Buy
45,091
+20,449
+83% +$1.11M ﹤0.01% 3805
2022
Q3 		$1.38M Buy
24,642
+2,120
+9% +$140K ﹤0.01% 4294
2022
Q2 		$1.63M Sell
22,522
-9,179
-29% -$684K ﹤0.01% 4217
2022
Q1 		$2.52M Sell
31,701
-39,615
-56% -$3.57M ﹤0.01% 4033
2021
Q4 		$7.22M Buy
71,316
+49,023
+220% +$4.89M ﹤0.01% 3063
2021
Q3 		$2.06M Sell
22,293
-54,050
-71% -$5.2M ﹤0.01% 4175
2021
Q2 		$7.82M Sell
76,343
-14,461
-16% -$1.45M ﹤0.01% 2927
2021
Q1 		$8.86M Sell
90,804
-82,996
-48% -$7.55M ﹤0.01% 2671
2020
Q4 		$13.4M Sell
173,800
-23,053
-12% -$1.78M ﹤0.01% 2212
2020
Q3 		$14.5M Sell
196,853
-6,756
-3% -$542K ﹤0.01% 1998
2020
Q2 		$15M Buy
203,609
+124,577
+158% +$9.77M ﹤0.01% 1921
2020
Q1 		$4.57M Buy
79,032
+559
+0.7% +$38.9K ﹤0.01% 2720
2019
Q4 		$6.16M Sell
78,473
-3,378
-4% -$249K ﹤0.01% 2791
2019
Q3 		$5.6M Sell
81,851
-43,702
-35% -$2.93M ﹤0.01% 2770
2019
Q2 		$9.97M Buy
125,553
+4,627
+4% +$367K ﹤0.01% 2358
2019
Q1 		$10.1M Buy
120,926
+64,599
+115% +$6.74M ﹤0.01% 2400
2018
Q4 		$6.63M Sell
56,327
-57,476
-51% -$6.65M ﹤0.01% 2657
2018
Q3 		$13.7M Sell
113,803
-79,202
-41% -$9.83M ﹤0.01% 2208
2018
Q2 		$22.3M Buy
193,005
+85,981
+80% +$9.41M 0.01% 1800
2018
Q1 		$9.19M Buy
107,024
+70,668
+194% +$5.47M ﹤0.01% 2396
2017
Q4 		$2.69M Sell
36,356
-13,180
-27% -$882K ﹤0.01% 3544
2017
Q3 		$2.86M Sell
49,536
-12,940
-21% -$764K ﹤0.01% 3666
2017
Q2 		$4M Buy
62,476
+6,103
+11% +$376K ﹤0.01% 3245
2017
Q1 		$3.25M Buy
56,373
+29,162
+107% +$1.74M ﹤0.01% 3311
2016
Q4 		$1.67M Sell
27,211
-58,693
-68% -$3.82M ﹤0.01% 4020
2016
Q3 		$5.94M Buy
85,904
+1,064
+1% +$70.2K ﹤0.01% 2902
2016
Q2 		$4.73M Buy
84,840
+62,192
+275% +$3.75M ﹤0.01% 2918
2016
Q1 		$1.38M Sell
22,648
-58,520
-72% -$3.45M ﹤0.01% 3807
2015
Q4 		$5.18M Sell
81,168
-47,472
-37% -$3.08M ﹤0.01% 2789
2015
Q3 		$8.62M Buy
128,640
+53,190
+70% +$3.76M ﹤0.01% 2373
2015
Q2 		$5.16M Buy
75,450
+31,730
+73% +$2.01M ﹤0.01% 2929
2015
Q1 		$2.43M Sell
43,720
-33,962
-44% -$1.74M ﹤0.01% 3586
2014
Q4 		$3.98M Sell
77,682
-20,602
-21% -$1.01M ﹤0.01% 3203
2014
Q3 		$3.62M Sell
98,284
-45,084
-31% -$1.63M ﹤0.01% 3344
2014
Q2 		$5.6M Sell
143,368
-33,590
-19% -$1.25M ﹤0.01% 2916
2014
Q1 		$6.67M Sell
176,958
-32,740
-16% -$1.14M ﹤0.01% 2727
2013
Q4 		$7.92M Sell
209,698
-15,608
-7% -$597K ﹤0.01% 2590
2013
Q3 		$9.78M Buy
225,306
+60,766
+37% +$2.44M ﹤0.01% 2278
2013
Q2 		$5.95M Buy
+164,540
New +$5M ﹤0.01% 2568

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs's USNA Position: Q1 2026 in Review

Goldman Sachs reduced its Usana Health Sciences (USNA) stake by 1.2% in Q1 2026, selling an estimated $22.5K and leaving 91,149 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #4733.

Goldman Sachs first reported a position in USNA in Q2 2013 and has held it in 52 quarters since. The position peaked at $22.3M in Q2 2018. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Goldman Sachs held 91,149 shares of Usana Health Sciences worth $1.59M as of Q1 2026.
  • Goldman Sachs sold 1,134 Usana Health Sciences shares in Q1 2026, an estimated $22.5K.
  • Usana Health Sciences made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4733 holding.
  • Goldman Sachs first reported a position in Usana Health Sciences in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Usana Health Sciences position peaked at $22.3M in Q2 2018.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.